Publications by authors named "Gerhard Arold"

Claim this Profile
M
Matching in Organ Impairment Studies: A Systematic Review of Accepted Methodologies.
Tatyana Dubich, Gerhard Arold, Karen L Smith, Thijs van Iersel, Ewoud-Jan van Hoogdalem

AAPS J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-discover the value of protein binding assessments in hepatic and renal impairment studies and its contributions in drug labels and dose decisions.
Jocelyn Courville, Kathryn Roupe, Gerhard Arold

Clin Transl Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers.
Lisa Seitz, Lixia Jin, Manmohan Leleti, Devika Ashok, Jenna Jeffrey, Gerhard Arold

Invest New Drugs· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp Substrates in Patients With an Advanced Solid Tumor.
Jim J Xiao, Dorota Nowak, Rodryg Ramlau, Monika Tomaszewska-Kiecana, Piotr J Wysocki, Gerhard Arold

Clin Transl Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment.
Lene Jensen, Viera Kupcova, Gerhard Arold, Jonas Pettersson, Julie B Hjerpsted

Diabetes Obes Metab· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin degludec: pharmacokinetics in patients with renal impairment.
István Kiss, Gerhard Arold, Carsten Roepstorff, Susanne Gammelgaard Bøttcher, Søren Klim

Clin Pharmacokinet· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin degludec: pharmacokinetic properties in subjects with hepatic impairment.
Viera Kupčová, Gerhard Arold, Carsten Roepstorff, Malene Højbjerre, Søren Klim

Clin Drug Investig· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of hepatic and renal impairment on the pharmacokinetics of dalcetrapib: altered distribution of the active thiol?
Mary Phelan, Judith Anzures-Cabrera, David J Carlile, Lucy Rowell, Olaf Kuhlmann, Gerhard Arold

Clin Pharmacokinet· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
Gerhard Arold, Frank Donath, Agathe Maurer, Konstanze Diefenbach, Steffen Bauer

Planta Med· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged > or = 50 years.
Konstanze Diefenbach, Gerhard Arold, Agnes Wollny, Ulrich Schwantes, Jutta Haselmann

BJU Int· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis